Skip to main content

AMERIPRISE FINANCIAL INC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 820027 MINNEAPOLIS, MN

Position in LGND

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$15,427,554
-$3,151,219 QoQ
Shares Held
77,273
-21.4% QoQ
Ownership
0.386%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 97.08953968397759.ToString("F0")% None 2.910460316022414.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. LGND ranks #32 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,427,554 77,273
2025-12-31 $18,578,773 98,264
2025-09-30 $17,934,184 101,243
2025-06-30 $12,469,899 109,693
2025-03-31 $13,356,038 127,031
2024-12-31 $10,254,683 95,704
2024-09-30 $9,402,954 93,945
2024-06-30 $8,429,454 100,041
2024-03-31 $8,501,018 116,293
2023-12-31 $7,611,585 106,575
2023-09-30 $8,115,743 135,443
2023-06-30 $10,533,376 146,094
2023-03-31 $9,748,758 132,528
2022-12-31 $9,023,142 135,077
2022-09-30 $7,736,089 144,013
2022-06-30 $8,356,060 150,132
2022-03-31 $7,813,810 111,348
2021-12-31 $10,796,777 112,050
2021-09-30 $9,623,417 110,726
2021-06-30 $7,458,596 91,136
2021-03-31 $8,764,492 92,158
2020-12-31 $10,433,186 168,169
2020-09-30 $12,270,529 206,354
2020-06-30 $31,861,261 456,626
2020-03-31 $15,032,157 331,361